We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+10.82%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$3.73B
AUM Growth
-$514M
(-12%)
Cap. Flow
-$749M
Cap. Flow
% of AUM
-20.06%
Top 10 Holdings %
Top 10 Hldgs %
29.58%
Holding
697
New
224
Increased
84
Reduced
80
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$156M |
| 2 |
Johnson & Johnson
JNJ
|
+$131M |
| 3 |
Walmart Inc
WMT
|
+$119M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$94.1M |
| 5 |
CELG
Celgene Corp
CELG
|
+$92.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$696M |
| 2 |
GE Aerospace
GE
|
+$139M |
| 3 |
Micron Technology
MU
|
+$126M |
| 4 |
Boeing
BA
|
+$104M |
| 5 |
Amazon
AMZN
|
+$71.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.97% |
| 2 | Healthcare | 16.06% |
| 3 | Technology | 11.89% |
| 4 | Financials | 10.27% |
| 5 | Communication Services | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
McCormick & Company Non-Voting
MKC
$14.3B
| $2.54M | 0.07% |
43,688
-60,452
| -58% | -$3.17M |
|
252
SS&C Technologies
SSNC
$18.7B
| $2.46M | 0.07% |
+47,437
| New | +$2.4M |
|
253
Costco
COST
$423B
| $2.46M | 0.07% |
+11,768
| New | +$2.32M |
|
254
Commault Systems
CVLT
$5.78B
| $2.44M | 0.07% |
+37,132
| New | +$2.55M |
|
255
Albemarle
ALB
$15.5B
| $2.42M | 0.06% |
25,686
-54,884
| -68% | -$5.27M |
|
256
F5
FFIV
$23.2B
| $2.42M | 0.06% |
+14,034
| New | +$2.34M |
|
257
Haemonetics
HAE
$3.94B
| $2.41M | 0.06% |
+26,855
| New | +$2.27M |
|
|
WW
258
DELISTED
WW International
WW
| $2.4M | 0.06% |
+23,723
| New | +$1.86M |
|
259
AMC Global Media
AMCX
$489M
| $2.36M | 0.06% |
+37,978
| New | +$2.17M |
|
260
SL Green Realty
SLG
$3.9B
| $2.36M | 0.06% |
+24,256
| New | +$2.29M |
|
261
CDW
CDW
$17.1B
| $2.31M | 0.06% |
+28,592
| New | +$2.21M |
|
262
Humana
HUM
$46.3B
| $2.29M | 0.06% |
7,694
+5,823
| +311% | +$1.71M |
|
263
Semtech
SMTC
$12.2B
| $2.28M | 0.06% |
+48,545
| New | +$2.18M |
|
|
HZNP
264
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.27M | 0.06% |
+137,219
| New | +$2.09M |
|
265
Franklin Resources
BEN
$17B
| $2.26M | 0.06% |
70,489
+62,289
| +760% | +$2.09M |
|
|
SCG
266
DELISTED
Scana
SCG
| $2.19M | 0.06% |
+56,954
| New | +$2.07M |
|
|
FRC
267
DELISTED
First Republic Bank
FRC
| $2.17M | 0.06% |
+22,370
| New | +$2.16M |
|
|
DOC
268
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $2.14M | 0.06% |
134,099
+48,160
| +56% | +$728K |
|
269
Pilgrim's Pride
PPC
$6.31B
| $2.12M | 0.06% |
105,338
-24,582
| -19% | -$528K |
|
270
Insperity
NSP
$1.96B
| $2.11M | 0.06% |
+22,169
| New | +$1.91M |
|
271
Sunrun
RUN
$2.38B
| $2.09M | 0.06% |
+159,223
| New | +$1.73M |
|
|
EXAS
272
DELISTED
Exact Sciences
EXAS
| $2.08M | 0.06% |
+34,719
| New | +$1.87M |
|
273
Supernus Pharmaceuticals
SUPN
$2.74B
| $2.02M | 0.05% |
+33,753
| New | +$1.75M |
|
274
Nu Skin
NUS
$250M
| $2.01M | 0.05% |
+25,726
| New | +$1.99M |
|
275
Cullen/Frost Bankers
CFR
$10.3B
| $1.99M | 0.05% |
+18,370
| New | +$2.07M |
|
Similar funds
AF
CS
KK
Voloridge Investment Management's Q2 2018 Portfolio in Review
As of Q2 2018, Voloridge Investment Management held 697 positions worth $3.73B, down 12% from $4.25B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Voloridge Investment Management withdrew a net $749M in Q2 2018, closing 309 positions and reducing 80 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $696M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Voloridge Investment Management opened a new position in iShares MSCI Emerging Markets ETF worth $146M.
- Voloridge Investment Management's largest Q2 2018 buy was iShares MSCI Emerging Markets ETF: 3,374,228 shares worth $146M.
- Voloridge Investment Management added most to Johnson & Johnson in Q2 2018, an estimated $131M increase.
- Voloridge Investment Management's biggest Q2 2018 reduction was GE Aerospace, cutting an estimated $139M.
- Voloridge Investment Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2018, selling an estimated $696M.
- Voloridge Investment Management's ten largest holdings make up 30% of its $3.73B portfolio in Q2 2018.
- Voloridge Investment Management opened 224 new positions and closed 309 in Q2 2018.
- Voloridge Investment Management's portfolio value fell 12% quarter-over-quarter to $3.73B.
Based on Voloridge Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.